Please select the option that best describes you:
Topics:
Hematologic Malignancies • Radiation Oncology • Internal Medicine • Hematology • Pediatric Hematology
How do you assess whether an early-stage Hodgkin's patient is unfavorable?
The unfavorable risk factors for stage I-II Classic Hodgkin's Lymphoma differ depending on the cooperative group (GHSG, EORTC, NCCN), which criteria do you use?
Answer from: Radiation Oncologist at Academic Institution
I personally utilize the GHSG criteria for most patients. To review, a patient has "favorable" disease if they meet all of the following criteria:
1. 1-2 involved sites
2. No bulky disease
3. No extranodal disease (which is rare in early-stage HL)
4. Favorable ESR/B-symptoms profile (ESR < 30...
Sign in or Register to read more